Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-12 04:31:30 EDT

Explore

PostsPeople
LatestRanked
@dhsc-answers.bsky.socialSep 15, 2026, 1:10 PM

A question on #Drugs #RareDiseases tabled by Peter Dowd on 28-08-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-08-28/21167

@dhsc-answers.bsky.socialSep 15, 2026, 1:10 PM

A question on #Drugs #RareDiseases tabled by Peter Dowd on 28-08-2026 has been answered by Mr James Frith. https://questions-statements.parliament.uk/written-questions/detail/2026-08-28/21169

@esendocrinology.bsky.socialSep 15, 2026, 8:05 AM

Don't miss ESE Talks... #RareDiseases webinar - Artificial Intelligence in Rare Disease - with ESE, Endo-ERN and ESPE.

📅 6 October, 17:00-18:30 (CEST)

Join chairs Sofia Llahana and Elena Valassi as well as our expert speakers.

Register now! 👉https://ow.ly/L02w50Yrl6y

@erdera.bsky.socialSep 15, 2026, 7:01 AM

👶 September is #NewbornScreening Awareness Month. Across Europe, access to comprehensive newborn screening remains uneven, contributing to avoidable inequalities in diagnosis and care.
Learn more in ERDERA's latest #ScientificPill👉 https://loom.ly/28UA3H8
#RareDiseases #ERDERA #HealthEquity

@drtimos.bsky.socialSep 14, 2026, 9:21 AM

🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVSzLc #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT

@4040rec.bsky.socialSep 14, 2026, 8:11 AM

#Hepatology #GileadSciences #Gilead #Livdelzi #seladelpar #Scotland #PBC #primarybiliarycholangitis #Pruritus #UDCA #NHSScotland #SMC #ScottishMedicinesConsortium #chronicitch #rarediseases #liverdisease #fibrosis #cirrhosis #liverfailure #PBCFoundation #RESPONSE #phase3
zurl.co/OHgLy

@czphenogenomics.bsky.socialSep 14, 2026, 8:04 AM

A huge thank you to all speakers, and especially to the patient organisations who made Session 8 on rare diseases & (gene) therapies so powerful. Your voices matter and the lively discussion showed why patients must be at the heart of research. 💙 #RareDiseases

@cgonzagaj.bsky.socialSep 11, 2026, 4:52 PM

Yesterday I had the honor of being recognized for my work in genetics & genomics of human diseases with the "Matilde Montoya Award for Women in Biological Sciences and Medicine". I am grateful for this honor & motivated to continue pushing genomics to improve the diagnosis of #RareDiseases

@czphenogenomics.bsky.socialSep 11, 2026, 10:01 AM

From genotype to phenotype 🧬 Thursday’s final session connected variant biology, precision medicine and therapy. Stanley T. Crooke presented n-Lorem’s approach to developing personalized ASOs for patients with pathogenic mutations—free for life. #CCPConference2026 #RareDiseases

@czphenogenomics.bsky.socialSep 11, 2026, 9:38 AM

From models to therapies 🔬
Yesterday’s Session 2 at #CCPConference2026 showcased how advanced preclinical models can bridge disease mechanisms and treatment:
The key message: the right model can turn genetic insight into therapeutic opportunity.
#RareDiseases #Phenogenomics

@drtimos.bsky.socialSep 10, 2026, 2:58 PM

🧬 Gene & Cell Therapy | #RareDiseases 🚀
#LucidQuest delivers sharp insights to help biotechs, investors & BD teams stay ahead in fast-moving markets.
📩 [email protected] or http://dlvr.it/TVQJZZ
#GeneTherapy #CellTherapy #Biotech #DueDiligence #InvestmentInsights

@erdera.bsky.socialSep 10, 2026, 9:40 AM

📬 Miss the September newsletter? Catch up on the latest updates and highlights from across ERDERA and the rare disease research community. Read it here 👉 https://loom.ly/VxVn5mI
📩 Don’t miss the next issue, subscribe now: https://loom.ly/TFRXEBY
#ERDERA #RareDiseases

@ipopi.bsky.socialSep 9, 2026, 2:10 PM

🌍 How can Europe better address the needs of people living with primary and secondary immunodeficiencies?

🔗 Read the full recommendations: bit.ly/4xgbJgq

#IPOPI #Immunodeficiencies #PrimaryImmunodeficiencies #EUHealth #HealthPolicy #RareDiseases

@gmj-georgia.bsky.socialSep 8, 2026, 10:41 PM

Breaking: Talos, a new automated tool, is reshaping rare disease diagnostics by systematically reanalysing stored genomic d… #Artificialintelligence #Clinicalgenomics #Genomicmedicine #Precisiondiagnostics #Rarediseases #Artificialintelligence #Clinicalgenomics #Genomicmedicine #Precisiondiagno…

@realised-ihi.bsky.socialSep 8, 2026, 8:05 AM

🎉First RealiseD publication available!
The assessment of randomisation methods used in clinical trials to minimise bias.

📰Read it: https://loom.ly/iSuP3KE
🔓Access article: https://doi.org/10.1371/journal.pone.0339427

#RareDiseases @ihieurope.bsky.social

@healthcaretoday.bsky.socialSep 8, 2026, 6:54 AM

Sam Barrell, chief executive of LifeArc, explains what we need to do to turn discovery science into patient benefit and why the UK has the potential to position itself as a market leader for rare diseases.

healthcaretoday.com/article/life...

#RareDiseases #LifeSciences #ClinicalTrials

@apainprincess.bsky.socialSep 7, 2026, 4:23 PM

“People with #ChronicPain don’t get a break from feeling tired. We just have to keep going… The pain can be so intense that it just exhausts…physically and mentally.” When Your Chronic Pain Leaves You in a Constant State of Tiredness buff.ly/2QDK9qf #PainAwarenessMonth #RareDiseases

@nfbot.bsky.socialSep 7, 2026, 12:33 PM

#Merck #Ezmekly #NHSuse #HEOR #MarketAccess #MerckKGaA #Neurofibromatosis #NF1 #NFItherapy #rarediseases #Reimbursement #NICE #oralMEKinhibitor #plexiformneurofibromas #PN #PNassociatedwithNF1 #paediatrics #MHRA #NICEfinaldraftguidance #paediatricNF1patients

@4040rec.bsky.socialSep 7, 2026, 12:13 PM

#Merck #Ezmekly #NHSuse #HEOR #MarketAccess #MerckKGaA #Neurofibromatosis #NF1 #NFItherapy #rarediseases #Reimbursement #NICE #oralMEKinhibitor #plexiformneurofibromas #PN #PNassociatedwithNF1 #paediatrics #MHRA #NICEfinaldraftguidance #paediatricNF1patients #ReNeutrial #PNlesions
zurl.co/8MUea

@drtimos.bsky.socialSep 5, 2026, 8:00 AM

🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVL5wC #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT